Peer-reviewedLicence not statedJournal of the American Heart Association
Population Impact of the 2026 American College of Cardiology/American Heart Association Dyslipidemia Guideline on Lipid‐Lowering Therapy Eligibility Among US Adults
- 1Lakeland Regional Health Medical Center
Related
- Guideline‐Directed Treatment Eligibility and Burden of Untreated Stage‐1 Hypertension Under the 2025 American College of Cardiology/American Heart Association Hypertension Guideline: Insights From NHANES 2015 to 2020
- Dyslipidemia management in athletes: A comparative commentary on the 2026 ACC/AHA/Multisociety Guideline and contemporary sports cardiology recommendations.
- Lipoprotein(a) and statin indications in low-risk patients based on the 2026 ACC/AHA dyslipidemia guideline
- Implications of the 2026 Cardiovascular-Kidney-Metabolic Syndrome Guideline for GLP-1 Receptor Agonist and SGLT2 Inhibitor Eligibility Among US Adults
- Artificial intelligence in cardiology for non-experts: decoding key terms and understanding machine learning methodologies. A Scientific Statement of the ESC Working Group on e-Cardiology, the European Heart Rhythm Association (EHRA), the Association for Acute CardioVascular Care (ACVC), the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI), the European Association of Preventive Cardiology (EAPC), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Regulatory Affairs Committee, and the ESC Digital Cardiology and Artificial Intelligence Committee
BibTeX
@article{hyun2026population,
title = {{Population Impact of the 2026 American College of Cardiology/American Heart Association Dyslipidemia Guideline on Lipid‐Lowering Therapy Eligibility Among US Adults}},
author = {Sangho Hyun and Chia‐hung Sze and Satyajeet Singh and Padideh Daneii and Jeffrey L. Williams and Joel Fernandez},
journal = {Journal of the American Heart Association},
year = {2026},
month = nov,
doi = {10.1161/jaha.126.053443},
url = {https://www.ahajournals.org/doi/10.1161/JAHA.126.053443},
}
RIS
TY - JOUR
TI - Population Impact of the 2026 American College of Cardiology/American Heart Association Dyslipidemia Guideline on Lipid‐Lowering Therapy Eligibility Among US Adults
AU - Sangho Hyun
AU - Chia‐hung Sze
AU - Satyajeet Singh
AU - Padideh Daneii
AU - Jeffrey L. Williams
AU - Joel Fernandez
PY - 2026
DA - 2026/11/12
JO - Journal of the American Heart Association
DO - 10.1161/jaha.126.053443
UR - https://www.ahajournals.org/doi/10.1161/JAHA.126.053443
SN - 2047-9980
ER -